During the past decade, Fondazione Centro San Raffaele del Monte Tabor conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 25 clinical trials were completed, i.e. on average, 227.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 13 clinical trials were completed. i.e. 650% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione Centro San Raffaele del Monte Tabor" #1 sponsor was "Gilead Sciences" with 11 trials, followed by "Boehringer Ingelheim" with 10 trials sponsored, "AGC Biologics S.p.A." with 9 trials sponsored, "Andres J. M. Ferreri" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Centro San Raffaele del Monte Tabor" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Centro Studi Gised" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Centro San Raffaele del Monte Tabor" are "HIV Infections" (11 trials), "HIV" (4 trials), "HIV-1 Infection" (4 trials), "Acquired Immunodeficiency Syndrome" (2 trials) and "Hepatocellular Carcinoma" (2 trials). Many other conditions were trialed in "Fondazione Centro San Raffaele del Monte Tabor" in a lesser frequency.

Most popular intervention types in "Fondazione Centro San Raffaele del Monte Tabor" are "Drug" (51 trials), "Device" (4 trials), "Biological" (3 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "NGR-hTNF" (8 trials), "FTC/TDF" (5 trials), "Placebo" (5 trials), "RTV" (4 trials) and "ATV" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Centro San Raffaele del Monte Tabor" are 53 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fondazione Centro San Raffaele del Monte Tabor". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Fondazione Centro San Raffaele del Monte Tabor, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Centro San Raffaele del Monte Tabor, 3 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".